Search results
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 6 hours agoBecause of this, empirical studies indicate a strong correlation between trends in earnings estimate...
Investing in Pfizer Inc.
Knox Daily· 4 days agoIn the deal valued at $26.47 per share,3,000 shares were bought. As a result of this transaction...shares worth roughly $0.25 million. Argus downgraded ...
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report - Pfizer...
Benzinga· 1 day agoIn a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc....
Top Stock Reports for Amazon.com, Visa & Pfizer
Zacks via Yahoo Finance· 7 days agoMarietta (MLM), Weather Woes Ail Per the Zacks analyst, robust infrastructure demand, efficient implementation of SOAR... analyst is impressed with...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 3 days agoShares now have a top Relative Strength Rating of 99. The RS Rating pits all stocks, regardless of...
One stock is dragging down the S&P 500's earnings growth
Yahoo Finance via AOL· 4 days agoPfizer (PFE) and Gilead Sciences (GILD). Gilead Sciences reported a loss per share of $1.32 in the...
Trending tickers: Tesla, Reddit, Walmart and GSK
Yahoo Finance UK· 10 hours agoAdjusted earnings per share are forecast to be at the high end or slightly higher than its original guidance of...businesses of British pharmaceutical...
7 Cheap Value Stocks to Buy Now: May 2024
InvestorPlace· 2 days agoThe major stock market indexes are near record highs. The good news, however, is that investors can still put money to work in today’s market without...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 days agoIn the first quarter, Halozyme earned an adjusted 79 cents per share on $196 million in sales, up a...
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
Zacks via Yahoo Finance· 5 hours agoThough obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect...